2,3-dihydro-1H-pyrrolo(3,4-c)pyridin-1-one derivatives as HPK1 inhibitors for the treatment of cancer

This invention relates to 2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-1-one derivatives of general Formula (I) and pharmaceutically acceptable salts thereof, as hematopoietic progenitor kinase 1 (HPK1) inhibitors, in which R

Saved in:
Bibliographic Details
Main Authors JALAIE, Mehran, ZHOU, Ru, TUTTLE, Jamison Bryce, MCTIGUE, Michele Ann, NAIR, Sajiv Krishnan, ZHOU, Dahui, SCHMITT, Anne-Marie Dechert, AHMAD, Omar Khaled, JOHNSON, Ted William, HE, Mingying, DEL BEL, Matthew L, GALLEGO, Rebecca Anne, KANIA, Robert Steven
Format Patent
LanguageEnglish
Published 15.09.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:This invention relates to 2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-1-one derivatives of general Formula (I) and pharmaceutically acceptable salts thereof, as hematopoietic progenitor kinase 1 (HPK1) inhibitors, in which R
Bibliography:Application Number: AU20190378184